Delta opioid receptors on parvalbumin cells are necessary for the convulsant and anxiolytic effects of the delta agonist SNC80

The delta opioid receptor (DOR) is expressed broadly throughout the central and peripheral nervous systems. Activation of DOR by exogenous and endogenous ligands regulates pain, motivation, emotion, and memory, but the cells and neural circuits mediating these behavioral effects remain poorly characterized. Parvalbumin-expressing interneurons (PV-INs) express high levels of DOR transcript (OPRD1) and protein. PV-INs also play a role in pain and emotional processing, suggesting that DOR signaling on PV-INs may modulate these behaviors. To address this question, we used a conditional knockout mouse line (Floxed DOR; PV-cre) to delete DOR from parvalbumin-expressing cells. First, we validated the functional loss of DOR through whole-cell electrophysiology experiments. Next, we characterized baseline behavioral phenotypes and the convulsant, pro-locomotive, and anxiolytic-like behavioral responses induced by the DOR agonist SNC80 in Floxed DOR; PV-Cre mice and their littermate controls. Interestingly, we found that the convulsant and anxiolytic effects of the DOR agonist SNC80 were diminished in Floxed DOR; PV-Cre animals. However, baseline behavioral phenotypes, SNC80-induced spontaneous hyperlocomotion and respiratory stimulation were conserved. These novel findings indicate that the pro-convulsant and anxiolytic effects of DOR agonists are anatomically separable from the locomotor stimulating effects and are dependent on DOR expression on PV-INs.